Research map: Subtype-Specific Probefor Estrogen Receptor α(ERα) Reveals Imaging of PROTAC-Induced Degradation

Back to the article

Papers in this map

  1. BODIPY Dyes and Their Derivatives: Syntheses and Spectroscopic Properties · Aurore Loudet · 2007 · 5221 citations · Cited by this paper
  2. Cross-Modality DeepLearning Denoising for Low-DoseμSPECT: Transfer of PET-Trained U-Net and Diffusion Models · 2026 · Related
  3. Comparison of the Ligand Binding Specificity and Transcript Tissue Distribution of Estrogen Receptors α and β · George G. J. M. Kuiper · 1997 · 4459 citations · Cited by this paper
  4. Pathogen-Specific PETImaging of Pulmonary InfectionUsing [18F]Fluoromannitol · 2026 · Related
  5. Molecular basis of agonism and antagonism in the oestrogen receptor · Andrzej Marek Brzozowski · 1997 · 3376 citations · Cited by this paper
  6. A GRPR Antagonist Peptide-BasedPretargeting StrategyOvercoming Molecule Internalization for Enhanced Tumor Imaging · 2026 · Related
  7. PROTAC targeted protein degraders: the past is prologue · Miklós Békés · 2022 · 3299 citations · Cited by this paper
  8. An Open, IntegratedPlatform for Multiplexed BioluminescenceMicroscopy · 2026 · Related
  9. The Chemistry of Fluorescent Bodipy Dyes: Versatility Unsurpassed · Gilles Ulrich · 2007 · 3166 citations · Cited by this paper
  10. Background-Free Stimulated Raman Scattering Imaging via Donut-Shaped Detection · 2026 · Related
  11. Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer · Jennet M. Harvey · 1999 · 2084 citations · Cited by this paper
  12. Electrochemical Imaging:Revealing Chemistry in Spaceand Time · 2026 · Related
  13. Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 Sites · Kolja Paech · 1997 · 1870 citations · Cited by this paper
  14. Multimodal BiophysicalAnalysis of Morpho-Phenotypicand Morpho-Functional Dynamics in Normal and Cancer Spheroids withinEngineered Microenvironments · 2026 · Related
  15. US Incidence of Breast Cancer Subtypes Defined by Joint Hormone Receptor and HER2 Status · Nadia Howlader · 2014 · 1551 citations · Cited by this paper
  16. Label-Free Raman ImagingDefines Distinct Cell Populationsin Human Skin · 2026 · Related
  17. BODIPY-based probes for the fluorescence imaging of biomolecules in living cells · Toshiyuki Kowada · 2015 · 1397 citations · Cited by this paper
  18. Catheter-Integrated Nanosensors Unmask Bladder Cancer · 2026 · Related
  19. Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. · Yolande Berthois · 1986 · 1328 citations · Cited by this paper
  20. Mechanisms and Applications of Photocatalytic ProximityLabeling · 2026 · Related
  21. Advanced Fluorescence Imaging Technology in the Near-Infrared-II Window for Biomedical Applications · Chunyan Li · 2020 · 1040 citations · Cited by this paper
  22. Structure of the ligand‐binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist · Ashley C. W. Pike · 1999 · 982 citations · Cited by this paper
  23. Lipophilicity in drug discovery · Michael J. Waring · 2010 · 880 citations · Cited by this paper
  24. Relevance of Breast Cancer Cell Lines as Models for Breast Tumours: An Update · Marc Lacroix · 2004 · 785 citations · Cited by this paper
  25. Estrogen-Receptor Interaction · Elwood V. Jensen · 1973 · 767 citations · Cited by this paper
  26. Estrogen receptors alpha (ERα) and beta (ERβ): Subtype-selective ligands and clinical potential · Ilaria Paterni · 2014 · 734 citations · Cited by this paper
  27. Estrogen Receptors α and β Form Heterodimers on DNA · Shaun M. Cowley · 1997 · 694 citations · Cited by this paper
  28. The nuclear receptor superfamily: A structural perspective · Emily R. Weikum · 2018 · 509 citations · Cited by this paper
  29. Estrogen Signaling and Cardiovascular Disease · Elizabeth Murphy · 2011 · 498 citations · Cited by this paper
  30. Aromatase Inhibitors in the Treatment of Breast Cancer · Robert W. Brueggemeier · 2005 · 484 citations · Cited by this paper
  31. MCF-7: A human breast cancer cell line with estrogen, androgen, progesterone, and glucocorticoid receptors · Kathryn B. Horwitz · 1975 · 460 citations · Cited by this paper
  32. Paracrine signaling through the epithelial estrogen receptor α is required for proliferation and morphogenesis in the mammary gland · Sonia Mallepell · 2006 · 438 citations · Cited by this paper
  33. Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion · Nadine Platet · 2004 · 364 citations · Cited by this paper
  34. Estrogen receptor beta in the brain: From form to function · Michael James Weiser · 2007 · 248 citations · Cited by this paper
  35. Different Regions in Activation Function-1 of the Human Estrogen Receptor Required for Antiestrogen- and Estradiol-dependent Transcription Activation · Eileen M. McInerney · 1996 · 232 citations · Cited by this paper
  36. Optical Control of Small Molecule-Induced Protein Degradation · Yuta Naro · 2020 · 214 citations · Cited by this paper
  37. Oral Estrogen Receptor PROTAC Vepdegestrant (ARV-471) Is Highly Efficacious as Monotherapy and in Combination with CDK4/6 or PI3K/mTOR Pathway Inhibitors in Preclinical ER+ Breast Cancer Models · Sheryl M. Gough · 2024 · 193 citations · Cited by this paper
  38. Discordance between core needle biopsy (CNB) and excisional biopsy (EB) for estrogen receptor (ER), progesterone receptor (PgR) and HER2 status in early breast cancer (EBC) · Mónica Arnedos · 2009 · 183 citations · Cited by this paper
  39. Use of tamoxifen and raloxifene for breast cancer chemoprevention in 2010 · Erika A. Waters · 2012 · 181 citations · Cited by this paper

Source: OpenAlex (CC0)